Your browser doesn't support javascript.
loading
Cognitive screening and rehabilitation after cardiac arrest: only a few hurdles to take.
van Til, Janine A; Hemels, Martin E W; Hofmeijer, Jeannette.
  • van Til JA; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands. j.a.vantil@utwente.nl.
  • Hemels MEW; Department of Cardiology, Rijnstate Hospital, Arnhem, The Netherlands.
  • Hofmeijer J; Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Neth Heart J ; 32(1): 63-66, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38085507
ABSTRACT
Dutch and European guidelines recommend systematic screening for cognitive and emotional impairments in cardiac arrest survivors. We aimed to clarify opinions on cognitive screening and rehabilitation, identify barriers and facilitators for implementation in the Netherlands, and arrive at recommendations in this field. We conducted 22 semi-structured interviews with various stakeholders using the Tailored Implementation in Chronic Diseases checklist. There is broad-based acknowledgement of the relevance of cognitive impairment and a positive attitude regarding early cognitive screening among health professionals and patients. Barriers to implementation include a lack of practical recommendations on how, where and when to screen, insufficient knowledge of cognitive consequences of cardiac arrest, insufficient collaboration and knowledge sharing among different specialties within hospitals, insufficient resources, and insufficient evidence of the effectiveness of screening and therapy to justify financial compensation. Most of the identified barriers to implementation are solvable national guidelines need practical recommendations and knowledge gaps among healthcare workers can be bridged by in-hospital collaboration. Fulfilling these requirements should be sufficient for the implementation of simple screening and tailored advice. More extensive cognitive rehabilitation therapy needs stronger evidence of efficacy in order to warrant stronger guideline recommendations and financial reimbursement.
Palabras clave